Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 6;18(7):38.
doi: 10.1007/s11882-018-0791-9.

Sulfonamide Drug Allergy

Affiliations
Review

Sulfonamide Drug Allergy

Joshua M Dorn et al. Curr Allergy Asthma Rep. .

Abstract

Purpose of review: We sought to review past and current literature on sulfonamide drug allergy and distill it in a practical manner to assist the clinician, specifically focusing on cross-reactivity and desensitization.

Recent findings: There do not appear to be consistent genetic markers to reliably predict features of or the presence hypersensitivity reactions. Recent evidence continues to alleviate early concerns cross-reactivity between sulfonamide antibiotics and non-antibiotics. Sulfonamide drug allergy is frequently encountered by the practicing clinician. For sulfonamide antibiotics, delayed rash is the most common clinical manifestation. There is no current evidence to support avoidance of all non-antibiotic sulfonamides in those with a reported allergy to sulfonamide antibiotics, although certain scenarios require caution. Available evidence supports the cautious reintroduction of sulfonamide antibiotics via desensitization, which is usually well tolerated and should be considered in those with strong indications for trimethoprim-sulfamethoxazole and a reported sulfonamide allergy.

Keywords: Cross-reactivity; Cross-sensitivity; Drug allergy; Hypersensitivity; Sulfonamide.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Investig Allergol Clin Immunol. 2009;19(3):249-50 - PubMed
    1. Blood. 1994 Jul 1;84(1):176-83 - PubMed
    1. Adverse Drug React Toxicol Rev. 1996 Mar;15(1):9-50 - PubMed
    1. Br J Dermatol. 2016 Mar;174(3):621-4 - PubMed
    1. Cutis. 1982 Jun;29(6):551, 556, 565 passim - PubMed

MeSH terms

LinkOut - more resources